CN110430871A - 可压缩性改善的粒度受控的吡非尼酮的药物组合物及其制备方法 - Google Patents

可压缩性改善的粒度受控的吡非尼酮的药物组合物及其制备方法 Download PDF

Info

Publication number
CN110430871A
CN110430871A CN201880018876.5A CN201880018876A CN110430871A CN 110430871 A CN110430871 A CN 110430871A CN 201880018876 A CN201880018876 A CN 201880018876A CN 110430871 A CN110430871 A CN 110430871A
Authority
CN
China
Prior art keywords
pirfenidone
composition
tablet
preparation
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880018876.5A
Other languages
English (en)
Chinese (zh)
Inventor
尹良老
金正泌
崔墉焕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yungjin Pharmaceutical Co Ltd
Original Assignee
Yungjin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yungjin Pharmaceutical Co Ltd filed Critical Yungjin Pharmaceutical Co Ltd
Publication of CN110430871A publication Critical patent/CN110430871A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201880018876.5A 2017-03-02 2018-02-28 可压缩性改善的粒度受控的吡非尼酮的药物组合物及其制备方法 Pending CN110430871A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020170027228A KR20180100869A (ko) 2017-03-02 2017-03-02 피르페니돈의 입자크기 조절에 따른 타정성이 개선된 약제학적 조성물 및 이의 제조방법
KR10-2017-0027228 2017-03-02
PCT/KR2018/002484 WO2018160011A1 (ko) 2017-03-02 2018-02-28 피르페니돈의 입자크기 조절에 따른 타정성이 개선된 약제학적 조성물 및 이의 제조방법

Publications (1)

Publication Number Publication Date
CN110430871A true CN110430871A (zh) 2019-11-08

Family

ID=63370533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880018876.5A Pending CN110430871A (zh) 2017-03-02 2018-02-28 可压缩性改善的粒度受控的吡非尼酮的药物组合物及其制备方法

Country Status (4)

Country Link
JP (2) JP2020509053A (ko)
KR (1) KR20180100869A (ko)
CN (1) CN110430871A (ko)
WO (1) WO2018160011A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102199415B1 (ko) * 2019-02-18 2021-01-06 충북대학교 산학협력단 중합체 및 채널링제를 포함하는 피르페니돈 또는 이의 약학적으로 허용가능한 염의 지연 방출용 정제
WO2021215856A1 (ko) * 2020-04-22 2021-10-28 영진약품 주식회사 안전성과 안정성이 개선된 피르페니돈을 포함하는 장용성 제제 및 이의 제조방법

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060446A1 (en) * 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
CN102552203A (zh) * 2010-12-21 2012-07-11 北京德众万全医药科技有限公司 一种吡非尼酮片及其制备方法
CN102846569A (zh) * 2012-09-06 2013-01-02 北京万全德众医药生物技术有限公司 一种含吡非尼酮的药物组合物及其制备方法
CN102846555A (zh) * 2012-04-09 2013-01-02 珠海亿邦制药股份有限公司 一种以吡非尼酮为活性成分的固体制剂及其应用
CN103271886A (zh) * 2013-05-29 2013-09-04 南京正大天晴制药有限公司 一种吡非尼酮片剂及其制备方法
CN103957892A (zh) * 2011-07-19 2014-07-30 细胞治疗技术合伙股份有限公司 以缓释片剂形式制备含有吡非尼酮的药物组合物的方法及其在人慢性肾功能衰竭、***包膜挛缩和肝纤维化的复原中的应用
CN106176641A (zh) * 2015-02-05 2016-12-07 保宁制药株式会社 片剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ591443A (en) * 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
CA2937365C (en) * 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060446A1 (en) * 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
CN102552203A (zh) * 2010-12-21 2012-07-11 北京德众万全医药科技有限公司 一种吡非尼酮片及其制备方法
CN103957892A (zh) * 2011-07-19 2014-07-30 细胞治疗技术合伙股份有限公司 以缓释片剂形式制备含有吡非尼酮的药物组合物的方法及其在人慢性肾功能衰竭、***包膜挛缩和肝纤维化的复原中的应用
CN102846555A (zh) * 2012-04-09 2013-01-02 珠海亿邦制药股份有限公司 一种以吡非尼酮为活性成分的固体制剂及其应用
CN102846569A (zh) * 2012-09-06 2013-01-02 北京万全德众医药生物技术有限公司 一种含吡非尼酮的药物组合物及其制备方法
CN103271886A (zh) * 2013-05-29 2013-09-04 南京正大天晴制药有限公司 一种吡非尼酮片剂及其制备方法
CN106176641A (zh) * 2015-02-05 2016-12-07 保宁制药株式会社 片剂及其制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
庄越等: "《实用药物制剂技术》", 31 January 1999, 人民卫生出版社 *
韦超等: "《药剂学》", 31 August 2012, 河南科学技术出版社 *

Also Published As

Publication number Publication date
JP2020509053A (ja) 2020-03-26
KR20180100869A (ko) 2018-09-12
JP2022031527A (ja) 2022-02-18
WO2018160011A1 (ko) 2018-09-07

Similar Documents

Publication Publication Date Title
US7361676B2 (en) Solid preparation containing single crystal form
EP1049467B1 (en) Celecoxib compositions
JP5401327B2 (ja) 溶出性の改善された錠剤
EP1561472B2 (en) Solid preparation
EP3437646A1 (en) Oral preparation having exceptional elutability
TWI700100B (zh) 用於口服投藥之包含依澤替米貝（ｅｚｅｔｉｍｉｂｅ）及羅舒伐他汀（ｒｏｓｕｖａｓｔａｔｉｎ）的複合調配物及其製備方法
EP3661508B1 (en) Manufacturing method of oral dosage form containing berberine, oral dosage form containing berberine and use thereof
TWI727935B (zh) 含有細胞週期蛋白抑制劑固體分散體的醫藥組成物及其製備方法
CN106389360A (zh) 盐酸达泊西汀直压片及其制备方法
WO1999059552A1 (fr) Preparations a liberation controlee
CN110430871A (zh) 可压缩性改善的粒度受控的吡非尼酮的药物组合物及其制备方法
CA2761212A1 (en) Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of it manufacturing
RU2613192C1 (ru) Таблетки клозапина с пролонгированным высвобождением
JP2006176496A (ja) 固形剤およびその製造方法
KR20140022002A (ko) 고형 의약 조성물
EP2696857A1 (en) Pharmaceutical composition comprising bosentan
KR20190110771A (ko) 데페라시록스를 함유하는 소형 분산성 정제
KR101774690B1 (ko) 라록시펜과 비타민 d를 포함하는 복합제제
JP4756153B2 (ja) 低成分含量の錠剤の製造方法
AU2003267216A1 (en) Mannitol formulation for integrin receptor antagonist
CN115212206B (zh) 一种含吡非尼酮的药物组合物及其制备方法
US20080194560A1 (en) Disintegration promoters in solid dose wet granulation formulations
KR20190007370A (ko) 바제독시펜 또는 그의 약제학적으로 허용가능한 염, 및 콜레칼시페롤 또는 그의 약제학적으로 허용가능한 염을 포함하는 우수한 안정성 및 용출률을 갖는 복합제제
Pimple et al. Formulation and evaluation of immediate release tablets of s (-) metoprolol succinate using roller compaction approach
EP3213747B1 (en) Tablets with a high-content of active ingredients useful for treating hair loss or stimulating its growth

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination